Search research articles
Contact Us
Filters
Showing results (101-110 of 119) with videos related to
Page
of 12
Sort By:
Leukemia
|
November 5, 2013
Phase 2 study of oral panobinostat (LBH589) with or without erythropoietin in heavily transfusion-dependent IPSS low or int-1 MDS patients
U Platzbecker, H K Al-Ali, N Gattermann, et al.
Leukemia
|
January 17, 2017
Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study Group
N Jahn, M Agrawal, L Bullinger, et al.
Leukemia Research
|
June 30, 2015
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes
G Caocci, M T Voso, E Angelucci, et al.
Leukemia
|
June 22, 2013
Monosomal karyotype in MDS: explaining the poor prognosis?
J Schanz, H Tüchler, F Solé, et al.
Leukemia
|
February 1, 2017
Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failure
M Wattad, D Weber, K Döhner, et al.
Leukemia
|
January 23, 2024
The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification
K Nachtkamp, C Strupp, M Vukelja, et al.
Leukemia
|
November 25, 2016
Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis
F Thol, S Klesse, L Köhler, et al.
Leukemia
|
May 3, 2016
Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)
M Mossner, J-C Jann, D Nowak, et al.
Leukemia
|
July 5, 2016
Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group
F Theis, A Corbacioglu, V I Gaidzik, et al.
Leukemia
|
February 1, 2012
Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): a multicenter study
U Germing, M Lauseker, B Hildebrandt, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 119) with videos related to
Sort By:
Page
of 12
Leukemia
|
November 5, 2013
Phase 2 study of oral panobinostat (LBH589) with or without erythropoietin in heavily transfusion-dependent IPSS low or int-1 MDS patients
U Platzbecker, H K Al-Ali, N Gattermann, et al.
Leukemia
|
January 17, 2017
Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study Group
N Jahn, M Agrawal, L Bullinger, et al.
Leukemia Research
|
June 30, 2015
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes
G Caocci, M T Voso, E Angelucci, et al.
Leukemia
|
June 22, 2013
Monosomal karyotype in MDS: explaining the poor prognosis?
J Schanz, H Tüchler, F Solé, et al.
Leukemia
|
February 1, 2017
Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failure
M Wattad, D Weber, K Döhner, et al.
Leukemia
|
January 23, 2024
The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification
K Nachtkamp, C Strupp, M Vukelja, et al.
Leukemia
|
November 25, 2016
Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis
F Thol, S Klesse, L Köhler, et al.
Leukemia
|
May 3, 2016
Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)
M Mossner, J-C Jann, D Nowak, et al.
Leukemia
|
July 5, 2016
Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group
F Theis, A Corbacioglu, V I Gaidzik, et al.
Leukemia
|
February 1, 2012
Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): a multicenter study
U Germing, M Lauseker, B Hildebrandt, et al.
Page
of 12